| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/10/2005 | US20050031694 Methods for promoting growth of bone, ligament, and cartilage using zvegf4 |
| 02/10/2005 | US20050031646 Immunogens; polysaccharide conjugate antigens derived from pathogenic bacterium conjugated to protein D from Haemophilus influenzae |
| 02/10/2005 | US20050031645 Vaccine compositions |
| 02/10/2005 | US20050031644 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange |
| 02/10/2005 | US20050031642 Clonal lentogenic oncolytic strain of Newcastle Disease Virus and hemaglutinin-neuraminidase (HN) gene |
| 02/10/2005 | US20050031641 Recombinant vaccine against West Nile Virus |
| 02/10/2005 | US20050031639 Materials and methods for immunizing against FIV infection |
| 02/10/2005 | US20050031638 Vaccine |
| 02/10/2005 | US20050031637 Fusion protein from a protein of papillomaviruses and E protein of one or more papillomaviruses and/or excipients; the fusion protein contains no papillomavirus-unspecific epitopes; treating tumors of the larynx, cervix, penis, vulva or anus |
| 02/10/2005 | US20050031636 Papilloma virus capsomere vaccine formulations and methods of use |
| 02/10/2005 | US20050031635 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 02/10/2005 | US20050031634 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 02/10/2005 | US20050031633 Glucan binding protein and glucosyltransferase immunogens |
| 02/10/2005 | US20050031631 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them |
| 02/10/2005 | US20050031629 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 02/10/2005 | US20050031628 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/10/2005 | US20050031624 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 02/10/2005 | US20050031593 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 02/10/2005 | US20050031592 Methods and compositions for inducing immune responses and protective immunity by priming with alpha virus replicon vaccines |
| 02/10/2005 | US20050031590 Adenoviral vectors having a protein IX deletion |
| 02/10/2005 | US20050031588 2'-branched nucleosides and Flaviviridae mutation |
| 02/10/2005 | US20050031584 Interleukin-2:remodeling and glycoconjugation of interleukin-2 |
| 02/10/2005 | US20050031583 Uses of opg to modulate immune responses |
| 02/10/2005 | US20050031582 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 02/10/2005 | DE10333406A1 T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen T-regulatory cells containing galectins for the therapy and diagnosis of diseases |
| 02/10/2005 | CA2758178A1 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | CA2562415A1 Concentrated aqueous silk fibroin solutions free of organic solvents and uses thereof |
| 02/10/2005 | CA2537899A1 Tissue-specific targeting of therapeutic and imaging agents to caveolae |
| 02/10/2005 | CA2534382A1 Lafora's disease gene |
| 02/10/2005 | CA2534356A1 Scaffold-free self-organized 3d synthetic tissue |
| 02/10/2005 | CA2534353A1 Adipocyte complement related protein zacrp11 |
| 02/10/2005 | CA2534351A1 Accelerated vaccination |
| 02/10/2005 | CA2534299A1 System for producing dimeric proteins based on the escherichia coli hemolysin transport system |
| 02/10/2005 | CA2534275A1 Pichia methanolica secretory signal |
| 02/10/2005 | CA2534055A1 Antibody cdr polypeptide sequences with restricted diversity |
| 02/10/2005 | CA2533823A1 Process for preparation of flax protein isolate |
| 02/10/2005 | CA2533796A1 Crystalline tumor necrosis factor receptor 2 polypeptides |
| 02/10/2005 | CA2533789A1 Epha2 t-cell epitope agonists and uses therefor |
| 02/10/2005 | CA2533781A1 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 02/10/2005 | CA2533687A1 A method of producing an anticoagulation effect |
| 02/10/2005 | CA2533512A1 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | CA2533297A1 Anti-vegf antibodies |
| 02/10/2005 | CA2531988A1 Novel insulin derivatives |
| 02/10/2005 | CA2531684A1 Binding molecules against sars-coronavirus and uses thereof |
| 02/10/2005 | CA2531441A1 Hybrid toxins comprising shiga or shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 02/10/2005 | CA2531329A1 Family of 28 kda babesia proteins as vaccines |
| 02/10/2005 | CA2531231A1 Uranium-chelating peptides and uses thereof |
| 02/10/2005 | CA2530172A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | CA2529798A1 Methods of treating hepatocellular carcinoma with zvegf3 antagonists |
| 02/09/2005 | EP1505160A2 5'nucleases derived from thermostable DNA polymerase |
| 02/09/2005 | EP1505154A1 Vector with modified protease-dependent tropism |
| 02/09/2005 | EP1505153A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 02/09/2005 | EP1505150A1 Novel proteins and dnas thereof |
| 02/09/2005 | EP1505076A2 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 02/09/2005 | EP1505074A1 Histamine receptor h3 ordinary activity mutant and utilization thereof |
| 02/09/2005 | EP1505073A1 Genetically encoded bioindicators of calcium-ions |
| 02/09/2005 | EP1504764A1 Treatment of liver fibrosis with antagonists of alpha V beta 6 integrin |
| 02/09/2005 | EP1504266A2 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
| 02/09/2005 | EP1504124A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| 02/09/2005 | EP1504112A2 Development of a preventive vaccine for filovirus infection in primates |
| 02/09/2005 | EP1504111A2 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same |
| 02/09/2005 | EP1504106A2 Method of increasing plant organ and seed size in a plant |
| 02/09/2005 | EP1504104A1 Insect resistant plants and methods for making the same |
| 02/09/2005 | EP1504103A1 Promoters having a modified transcription efficiency and derived from methyltrophic yeast |
| 02/09/2005 | EP1504101A2 Intracellular signaling molecules |
| 02/09/2005 | EP1504099A2 Novel nucleic acids and polypeptides |
| 02/09/2005 | EP1504098A2 A method for in vitro molecular evolution of protein function |
| 02/09/2005 | EP1504094A2 Peptide compounds and their use as protease substrates |
| 02/09/2005 | EP1504090A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/09/2005 | EP1504089A2 Allergen mutants |
| 02/09/2005 | EP1504037A2 Ferritin fusion proteins for use in vaccines and other applications |
| 02/09/2005 | EP1504036A2 Toxin-related antibodies with antimicrobial and antiviral activity |
| 02/09/2005 | EP1504033A2 Connective tissue stimulating peptides |
| 02/09/2005 | EP1504032A1 Method, use and kit for separating albumin from contaminants in a liquid |
| 02/09/2005 | EP1504031A1 Method for albumin purification |
| 02/09/2005 | EP1504030A2 Constitutively translocating cell line |
| 02/09/2005 | EP1504029A2 Expression system for large functional proteins |
| 02/09/2005 | EP1504028A2 In vitro bioassay for determining the activity of glycoprotein hormones |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
| 02/09/2005 | EP1504026A2 Therapeutic polypeptides, nucleic acids encodings same, and methods of use |
| 02/09/2005 | EP1504025A2 Nucleic acids and proteins from streptococcus groups a & b |
| 02/09/2005 | EP1504022A2 Process for the synthesis of peptide amides by side-chain attachment to a solid phase |
| 02/09/2005 | EP1504017A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 02/09/2005 | EP1503794A1 Methods of treatement using ctla-4 antibodies |
| 02/09/2005 | EP1503792A2 Attenuation of metapneumovirus |
| 02/09/2005 | EP1503785A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 02/09/2005 | EP1503780A2 Androgen-regulated pmepa1 gene and methods of using the same to inhibit cancer cell growth |
| 02/09/2005 | EP1503767A2 Compositions and methods for treatment of vitamin d deficiency |
| 02/09/2005 | EP1503749A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 02/09/2005 | EP1503745A2 15625 receptor, a novel g-protein coupled receptor |
| 02/09/2005 | EP1456223A4 Rapidly maturing fluorescent proteins and methods for using the same |
| 02/09/2005 | EP1438335A4 Ferroportin-1 mutant |
| 02/09/2005 | EP1399572A4 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants |
| 02/09/2005 | EP1327143A4 Crystal structure of bace and uses thereof |
| 02/09/2005 | EP1051427A4 Spoil protein and nucleic acid molecules and uses therefor |
| 02/09/2005 | EP1030923B1 Method for producing virus-like particles on the basis of polyoma viruses |
| 02/09/2005 | EP1017805B1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 02/09/2005 | EP1009805A4 TRANSGENIC PLANTS OF ALTERED MORPHOLOGY AND THE ISOLATED $i(ARABIDOPSIS THALIANA) ENDO-1,4-$g(b)-GLUCANASE GENE, PROMOTER AND PROTEIN |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | EP0383799B2 Adheson variants |